122 related articles for article (PubMed ID: 17131701)
1. [New medications; ziconotide].
Cohen AF; van Bronswijk H
Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2427-8. PubMed ID: 17131701
[TBL] [Abstract][Full Text] [Related]
2. Ziconotide: a new option for refractory pain.
Prommer E
Drugs Today (Barc); 2006 Jun; 42(6):369-78. PubMed ID: 16845440
[TBL] [Abstract][Full Text] [Related]
3. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
Klotz U
Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
[TBL] [Abstract][Full Text] [Related]
4. Ziconotide: can we use it in palliative care?
Prommer EE
Am J Hosp Palliat Care; 2005; 22(5):369-74. PubMed ID: 16225359
[TBL] [Abstract][Full Text] [Related]
5. Ziconotide: an update and review.
Williams JA; Day M; Heavner JE
Expert Opin Pharmacother; 2008 Jun; 9(9):1575-83. PubMed ID: 18518786
[TBL] [Abstract][Full Text] [Related]
6. Ziconotide for treatment of severe chronic pain.
Schmidtko A; Lötsch J; Freynhagen R; Geisslinger G
Lancet; 2010 May; 375(9725):1569-77. PubMed ID: 20413151
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal therapy with ziconotide: clinical experience and considerations on its use.
Vitale V; Battelli D; Gasperoni E; Monachese N
Minerva Anestesiol; 2008 Dec; 74(12):727-33. PubMed ID: 19034250
[TBL] [Abstract][Full Text] [Related]
8. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.
Miljanich GP
Curr Med Chem; 2004 Dec; 11(23):3029-40. PubMed ID: 15578997
[TBL] [Abstract][Full Text] [Related]
9. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
Wermeling DP
Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
[TBL] [Abstract][Full Text] [Related]
10. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
Wallace MS
Expert Rev Neurother; 2006 Oct; 6(10):1423-8. PubMed ID: 17078783
[TBL] [Abstract][Full Text] [Related]
11. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
[TBL] [Abstract][Full Text] [Related]
12. Elan: ziconotide review focused on off-label uses.
Narayana AK
Am J Hosp Palliat Care; 2005; 22(6):408. PubMed ID: 16323709
[No Abstract] [Full Text] [Related]
13. Ziconitide.
Greenberg EN
J Pain Palliat Care Pharmacother; 2011; 25(4):380-1. PubMed ID: 22126177
[TBL] [Abstract][Full Text] [Related]
14. Ziconotide.
Strigenz T
J Pain Palliat Care Pharmacother; 2014 Mar; 28(1):73-4. PubMed ID: 24397285
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of intrathecal ziconotide for the treatment of chronic pain.
Jain KK
Expert Opin Investig Drugs; 2000 Oct; 9(10):2403-10. PubMed ID: 11060815
[TBL] [Abstract][Full Text] [Related]
16. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
[TBL] [Abstract][Full Text] [Related]
17. New aspects in performing interventional techniques for chronic pain.
Zuurmond WW; Perez RS; Loer SA
Curr Opin Support Palliat Care; 2007 Aug; 1(2):132-6. PubMed ID: 18685354
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal ziconotide for neuropathic pain: a review.
Rauck RL; Wallace MS; Burton AW; Kapural L; North JM
Pain Pract; 2009; 9(5):327-37. PubMed ID: 19682321
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal ziconotide for refractory chronic pain.
Lynch SS; Cheng CM; Yee JL
Ann Pharmacother; 2006; 40(7-8):1293-300. PubMed ID: 16849624
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
